Opus Genetics, Inc. Stock-Based Compensation
Opus Genetics, Inc. (IRD) reported Stock-Based Compensation of $2.87 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-06
- Opus Genetics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $1.41M, a 57.03% increase year-over-year.
- Opus Genetics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $1.46M, a 60.35% increase year-over-year.
- Opus Genetics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $774.00K, a 2.64% decline year-over-year.
- Opus Genetics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $816.00K, a 5.15% increase year-over-year.
- Opus Genetics, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $3.40M, a 1.10% increase from fiscal 2024.
- Opus Genetics, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $3.36M, a 4.22% decline from fiscal 2023.
- Opus Genetics, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $3.51M, a 94.24% increase from fiscal 2022.
- Opus Genetics, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $1.81M, a 5.59% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed | Share-based Payment Arrangement, Noncash Expense 132 month | Share-based Payment Arrangement, Noncash Expense 135 month | Share-based Payment Arrangement, Noncash Expense 138 month | Share-based Payment Arrangement, Noncash Expense 141 month | Share-based Payment Arrangement, Noncash Expense 144 month | Share-based Payment Arrangement, Noncash Expense 147 month | Share-based Payment Arrangement, Noncash Expense 150 month | Share-based Payment Arrangement, Noncash Expense 153 month | Share-based Payment Arrangement, Noncash Expense 156 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.87M 10-Q · filed 2026-08-06 | $3.65M derived: sum of 3 quarters · filed 2026-08-06 | $4.46M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||||||
| 2026-03-31 | $1.46M 10-Q · filed 2026-05-12 | $2.24M derived: sum of 2 quarters · filed 2026-05-12 | $3.05M derived: sum of 3 quarters · filed 2026-05-12 | $3.95M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||||||
| 2025-12-31 | $774.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $1.59M derived: sum of 2 quarters · filed 2026-03-12 | $2.49M derived: sum of 3 quarters · filed 2026-08-06 | $3.40M 10-K · filed 2026-03-12 | |||||||||||||
| 2025-09-30 | $816.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.71M derived: sum of 2 quarters · filed 2026-08-06 | $2.63M 10-Q · filed 2025-11-12 | $3.42M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||||||
| 2025-06-30 | $896.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.81M 10-Q · filed 2026-08-06 | $2.60M derived: sum of 3 quarters · filed 2026-08-06 | $3.38M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||||||
| 2025-03-31 | $913.00K 10-Q · filed 2026-05-12 | $1.71M derived: sum of 2 quarters · filed 2026-05-12 | $2.48M derived: sum of 3 quarters · filed 2026-05-12 | $3.29M derived: sum of 4 quarters · filed 2026-05-12 | |||||||||||||
| 2024-12-31 | $795.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $1.57M derived: sum of 2 quarters · filed 2026-03-12 | $2.38M derived: sum of 3 quarters · filed 2026-03-12 | $3.36M 10-K · filed 2026-03-12 | |||||||||||||
| 2024-09-30 | $776.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.58M derived: sum of 2 quarters · filed 2025-11-12 | $2.57M 10-Q · filed 2025-11-12 | $3.28M derived: sum of 4 quarters · filed 2025-11-12 | |||||||||||||
| 2024-06-30 | $806.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $1.79M 10-Q · filed 2025-08-13 | $2.50M derived: sum of 3 quarters · filed 2025-08-13 | $3.08M derived: sum of 4 quarters · filed 2025-08-13 | |||||||||||||
| 2024-03-31 | $985.00K 10-Q · filed 2025-05-15 | $1.70M derived: sum of 2 quarters · filed 2025-05-15 | $2.27M derived: sum of 3 quarters · filed 2025-05-15 | $3.69M derived: sum of 4 quarters · filed 2025-05-15 | |||||||||||||
| 2023-12-31 | $711.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $1.28M derived: sum of 2 quarters · filed 2025-03-31 | $2.71M derived: sum of 3 quarters · filed 2025-03-31 | $3.51M 10-K · filed 2025-03-31 | |||||||||||||
| 2023-09-30 | $573.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $2.00M derived: sum of 2 quarters · filed 2024-11-12 | $2.80M 10-Q · filed 2024-11-12 | $3.22M derived: sum of 4 quarters · filed 2024-11-12 | |||||||||||||
| 2023-06-30 | $1.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $2.23M 10-Q · filed 2024-08-13 | $2.65M derived: sum of 3 quarters · filed 2024-08-13 | $3.14M derived: sum of 4 quarters · filed 2024-08-13 | |||||||||||||
| 2023-03-31 | $804.00K 10-Q · filed 2024-05-10 | $1.23M derived: sum of 2 quarters · filed 2024-05-10 | $1.72M derived: sum of 3 quarters · filed 2024-05-10 | $2.17M derived: sum of 4 quarters · filed 2024-05-10 | |||||||||||||
| 2022-12-31 | $424.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $917.00K derived: sum of 2 quarters · filed 2024-03-08 | $1.36M derived: sum of 3 quarters · filed 2024-03-08 | $1.81M 10-K · filed 2024-03-08 | |||||||||||||
| 2022-09-30 | $493.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $938.00K derived: sum of 2 quarters · filed 2023-11-13 | $1.38M 10-Q · filed 2023-11-13 | $1.86M derived: sum of 4 quarters · filed 2023-11-13 | |||||||||||||
| 2022-06-30 | $445.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $890.00K 10-Q · filed 2023-08-11 | $1.37M derived: sum of 3 quarters · filed 2023-08-11 | $1.85M derived: sum of 4 quarters · filed 2023-08-11 | |||||||||||||
| 2022-03-31 | $445.00K 10-Q · filed 2023-05-15 | $924.00K derived: sum of 2 quarters · filed 2023-05-15 | $1.40M derived: sum of 3 quarters · filed 2023-05-15 | $1.86M derived: sum of 4 quarters · filed 2023-05-15 | |||||||||||||
| 2021-12-31 | $479.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $957.00K derived: sum of 2 quarters · filed 2023-03-30 | $1.42M derived: sum of 3 quarters · filed 2023-03-30 | $1.91M 10-K · filed 2023-03-30 | |||||||||||||
| 2021-09-30 | $478.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $941.00K derived: sum of 2 quarters · filed 2022-11-04 | $1.44M 10-Q · filed 2022-11-04 | $1.95M derived: sum of 4 quarters · filed 2022-11-04 | |||||||||||||
| 2021-06-30 | $463.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $957.00K 10-Q · filed 2022-08-12 | $1.47M derived: sum of 3 quarters · filed 2022-08-12 | $2.09M derived: sum of 4 quarters · filed 2022-08-12 | |||||||||||||
| 2021-03-31 | $494.00K 10-Q · filed 2022-05-13 | $1.01M derived: sum of 2 quarters · filed 2022-05-13 | $1.62M derived: sum of 3 quarters · filed 2022-05-13 | $1.94M derived: sum of 4 quarters · filed 2022-05-13 | |||||||||||||
| 2020-12-31 | $513.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $1.13M derived: sum of 2 quarters · filed 2022-03-24 | $1.45M derived: sum of 3 quarters · filed 2022-03-24 | $1.51M 10-K · filed 2022-03-24 | |||||||||||||
| 2020-09-30 | $616.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $932.00K derived: sum of 2 quarters · filed 2021-11-12 | $993.00K 10-Q · filed 2021-11-12 | $202.21K 10-Q · filed 2020-10-29 | $921.65K derived: sum of 4 quarters · filed 2021-11-12 | ||||||||||||
| 2020-06-30 | $316.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $377.00K 10-Q · filed 2021-08-12 | $145.37K 10-Q · filed 2020-08-14 | $305.65K derived: sum of 3 quarters · filed 2021-08-12 | $396.35K derived: sum of 4 quarters · filed 2021-08-12 | ||||||||||||
| 2020-03-31 | $61.00K 10-Q · filed 2021-05-07 | $76.30K 10-Q · filed 2020-05-07 | -$10.35K derived: sum of 2 quarters · filed 2021-05-07 | $80.35K derived: sum of 3 quarters · filed 2021-05-07 | $208.00K derived: sum of 4 quarters · filed 2021-05-07 | ||||||||||||
| 2019-12-31 | -$71.35K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $19.35K derived: sum of 2 quarters · filed 2021-03-11 | $147.00K derived: sum of 3 quarters · filed 2021-03-11 | $308.00K 10-K · filed 2021-03-11 | $456.75K 10-K · filed 2020-02-21 | ||||||||||||
| 2019-09-30 | $90.69K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $218.35K derived: sum of 2 quarters · filed 2020-10-29 | $379.35K 10-Q · filed 2020-10-29 | $762.47K derived: sum of 4 quarters · filed 2020-10-29 | |||||||||||||
| 2019-06-30 | $127.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $288.65K 10-Q · filed 2020-08-14 | $671.78K derived: sum of 3 quarters · filed 2020-08-14 | $953.26K derived: sum of 4 quarters · filed 2020-08-14 | |||||||||||||
| 2019-03-31 | $161.00K 10-Q · filed 2020-05-07 | $544.13K derived: sum of 2 quarters · filed 2020-05-07 | $825.61K derived: sum of 3 quarters · filed 2020-05-07 | $1.09M derived: sum of 4 quarters · filed 2020-05-07 | |||||||||||||
| 2018-12-31 | $383.13K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $664.61K derived: sum of 2 quarters · filed 2020-02-21 | $931.76K derived: sum of 3 quarters · filed 2020-02-21 | $1.23M 10-K · filed 2020-02-21 | |||||||||||||
| 2018-09-30 | $281.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $548.63K derived: sum of 2 quarters · filed 2019-11-06 | $845.21K 10-Q · filed 2019-11-06 | $1.10M derived: sum of 4 quarters · filed 2019-11-06 | |||||||||||||
| 2018-06-30 | $267.15K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $563.73K 10-Q · filed 2019-08-07 | $817.89K derived: sum of 3 quarters · filed 2019-08-07 | $1.05M derived: sum of 4 quarters · filed 2019-08-07 | |||||||||||||
| 2018-03-31 | $296.58K 10-Q · filed 2019-05-10 | $550.74K derived: sum of 2 quarters · filed 2019-05-10 | $778.35K derived: sum of 3 quarters · filed 2019-05-10 | $1.07M derived: sum of 4 quarters · filed 2019-05-10 | |||||||||||||
| 2017-12-31 | $254.16K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $481.77K derived: sum of 2 quarters · filed 2019-03-07 | $769.84K derived: sum of 3 quarters · filed 2019-03-07 | $1.04M 10-K · filed 2019-03-07 | |||||||||||||
| 2017-09-30 | $227.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | $515.68K derived: sum of 2 quarters · filed 2018-11-02 | $790.01K 10-Q · filed 2018-11-02 | $1.14M derived: sum of 4 quarters · filed 2018-11-02 | |||||||||||||
| 2017-06-30 | $288.06K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | $562.39K 10-Q · filed 2018-08-03 | $908.29K derived: sum of 3 quarters · filed 2018-08-03 | $1.28M derived: sum of 4 quarters · filed 2018-08-03 | |||||||||||||
| 2017-03-31 | $274.33K 10-Q · filed 2018-05-04 | $620.23K derived: sum of 2 quarters · filed 2018-05-04 | $989.63K derived: sum of 3 quarters · filed 2018-05-04 | $1.34M derived: sum of 4 quarters · filed 2018-05-04 | |||||||||||||
| 2016-12-31 | $345.90K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $715.30K derived: sum of 2 quarters · filed 2018-03-09 | $1.07M derived: sum of 3 quarters · filed 2018-03-09 | $1.41M 10-K · filed 2018-03-09 | |||||||||||||
| 2016-09-30 | $369.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $720.58K derived: sum of 2 quarters · filed 2017-11-03 | $1.06M 10-Q · filed 2017-11-03 | $1.33M derived: sum of 4 quarters · filed 2018-03-09 | |||||||||||||
| 2016-06-30 | $351.18K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $694.19K 10-Q · filed 2017-08-04 | $962.20K derived: sum of 3 quarters · filed 2018-03-09 | $1.19M derived: sum of 4 quarters · filed 2018-03-09 | |||||||||||||
| 2016-03-31 | $343.01K 10-Q · filed 2017-05-03 | $611.02K derived: sum of 2 quarters · filed 2018-03-09 | $836.34K derived: sum of 3 quarters · filed 2018-03-09 | $1.11M derived: sum of 4 quarters · filed 2018-03-09 | |||||||||||||
| 2015-12-31 | $268.01K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $493.33K derived: sum of 2 quarters · filed 2018-03-09 | $765.29K derived: sum of 3 quarters · filed 2018-03-09 | $1.04M 10-K · filed 2018-03-09 | |||||||||||||
| 2015-09-30 | $225.32K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $497.28K derived: sum of 2 quarters · filed 2016-11-04 | $769.67K 10-Q · filed 2016-11-04 | $954.40K derived: sum of 4 quarters · filed 2017-02-24 | |||||||||||||
| 2015-06-30 | $271.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $544.35K 10-Q · filed 2016-08-05 | $729.09K derived: sum of 3 quarters · filed 2017-02-24 | $892.28K derived: sum of 4 quarters · filed 2017-02-24 | |||||||||||||
| 2015-03-31 | $272.39K 10-Q · filed 2016-05-06 | $457.12K derived: sum of 2 quarters · filed 2017-02-24 | $620.31K derived: sum of 3 quarters · filed 2017-02-24 | $752.83K derived: sum of 4 quarters · filed 2017-02-24 | |||||||||||||
| 2014-12-31 | $184.74K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $347.93K derived: sum of 2 quarters · filed 2017-02-24 | $480.44K derived: sum of 3 quarters · filed 2017-02-24 | $608.79K 10-K · filed 2017-02-24 | |||||||||||||
| 2014-09-30 | $163.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $295.71K derived: sum of 2 quarters · filed 2015-11-02 | $424.06K 10-Q · filed 2015-11-02 | $495.45K derived: sum of 4 quarters · filed 2016-03-14 | |||||||||||||
| 2014-06-30 | $132.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $260.87K 10-Q · filed 2015-08-07 | $332.26K derived: sum of 3 quarters · filed 2016-03-14 | $399.97K derived: sum of 4 quarters · filed 2016-03-14 | |||||||||||||
| 2014-03-31 | $128.35K 10-Q · filed 2015-05-08 | $199.74K derived: sum of 2 quarters · filed 2016-03-14 | $267.46K derived: sum of 3 quarters · filed 2016-03-14 | $321.83K derived: sum of 4 quarters · filed 2016-03-14 | $6.50M 10-Q · filed 2014-05-14 | ||||||||||||
| 2013-12-31 | $71.39K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $139.11K derived: sum of 2 quarters · filed 2016-03-14 | $193.48K derived: sum of 3 quarters · filed 2016-03-14 | $565.43K 10-K · filed 2016-03-14 | $6.37M 10-K · filed 2014-03-21 | ||||||||||||
| 2013-09-30 | $67.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $122.09K derived: sum of 2 quarters · filed 2014-11-12 | $494.04K 10-Q · filed 2014-11-12 | $522.49K derived: sum of 4 quarters · filed 2014-11-12 | $6.30M 10-Q · filed 2013-11-13 | ||||||||||||
| 2013-06-30 | $54.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13 | $426.32K 10-Q · filed 2014-08-13 | $454.77K derived: sum of 3 quarters · filed 2014-08-13 | $515.38K derived: sum of 4 quarters · filed 2014-08-13 | $6.23M 10-Q · filed 2013-08-12 | ||||||||||||
| 2013-03-31 | $371.95K 10-Q · filed 2014-05-14 | $400.40K derived: sum of 2 quarters · filed 2014-05-14 | $461.01K derived: sum of 3 quarters · filed 2014-05-14 | $511.76K derived: sum of 4 quarters · filed 2014-05-14 | $6.18M 10-Q · filed 2013-05-09 | ||||||||||||
| 2012-12-31 | $28.45K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21 | $89.06K derived: sum of 2 quarters · filed 2014-03-21 | $139.81K derived: sum of 3 quarters · filed 2014-03-21 | $230.99K 10-K · filed 2014-03-21 | $5.81M 10-K · filed 2013-03-22 | ||||||||||||
| 2012-09-30 | $60.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $111.36K derived: sum of 2 quarters · filed 2013-11-13 | $202.54K 10-Q · filed 2013-11-13 | $327.89K derived: sum of 4 quarters · filed 2013-11-13 | $5.78M 10-Q · filed 2012-11-08 | ||||||||||||
| 2012-06-30 | $50.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | $141.93K 10-Q · filed 2013-08-12 | $267.28K derived: sum of 3 quarters · filed 2013-08-12 | $408.37K derived: sum of 4 quarters · filed 2013-08-12 | $5.72M 10-Q · filed 2012-08-08 | ||||||||||||
| 2012-03-31 | $91.17K 10-Q · filed 2013-05-09 | $216.53K derived: sum of 2 quarters · filed 2013-05-09 | $357.61K derived: sum of 3 quarters · filed 2013-05-09 | $527.79K derived: sum of 4 quarters · filed 2013-05-09 | $5.67M 10-Q · filed 2012-05-09 | ||||||||||||
| 2011-12-31 | $125.35K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-22 | $266.44K derived: sum of 2 quarters · filed 2013-03-22 | $436.62K derived: sum of 3 quarters · filed 2013-03-22 | $638.61K 10-K · filed 2013-03-22 | |||||||||||||
| 2011-09-30 | $141.09K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $311.27K derived: sum of 2 quarters · filed 2012-11-08 | $513.25K 10-Q · filed 2012-11-08 | $662.61K derived: sum of 4 quarters · filed 2012-11-08 | |||||||||||||
| 2011-06-30 | $170.18K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $372.17K 10-Q · filed 2012-08-08 | $521.52K derived: sum of 3 quarters · filed 2012-08-08 | $633.12K derived: sum of 4 quarters · filed 2012-08-08 | |||||||||||||
| 2011-03-31 | $201.99K 10-Q · filed 2012-05-09 | $351.34K derived: sum of 2 quarters · filed 2012-05-09 | $462.94K derived: sum of 3 quarters · filed 2012-05-09 | ||||||||||||||
| 2010-12-31 | $149.35K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-16 | $260.95K derived: sum of 2 quarters · filed 2012-03-16 | $584.66K 10-K · filed 2012-03-16 | ||||||||||||||
| 2010-09-30 | $111.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $435.31K 10-Q · filed 2011-11-09 | |||||||||||||||
| 2010-06-30 | $323.70K 10-Q · filed 2011-08-09 | ||||||||||||||||
| 2009-12-31 | $497.53K 10-K · filed 2012-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |